ACET: adicetbio.com Kompaniya qiymatining sof foydaga nisbati
-0.30 indikatori bilan ko'rsatilgan ushbu ACET savdo grafigi hujayra terapiyasi patentlari va qat'iy FDA tartibga soluvchi qoidalari tomonidan ta'minlangan biznes himoyasini ta'kidlaydi. Adicet Bio onkologiya va autoimmun patologiya davolash segmentlarida kengayishni maqsad qilgan. Firmaning muvaffaqiyati klinik sinovlar samaradorligi, biomanufakturing kengayish imkoniyatlari va yakuniy tadqiqot bosqichlarining tasdiqlanishiga bog'liq.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwa76aez.ocr-7cpmfb4&start=20220704&end=20261110&filename=GURU_Markets_-_ACET_-_Adicet-Bio_-_PE-Multiple "ACET: Adicet Biznesning o‘zini qoplash muddati 04.07.2022 - 10.11.2026 | 👁️GURU.Markets👁️")
Adicet Bio Inc. (ACET) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Adicet Bio|ACET - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Adicet|ACET - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Adicet Bio, Inc.|ACET - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Adicet Bio|Tezkor likvidlik koeffitsiyenti adicetbio.com
- foyda va bozor multiplikatorlari tafsilotlari:
ACET - Sof foyda|Sof foyda prognozi Adicet Bio|ACET - P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Adicet|ACET - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti Adicet Bio, Inc.|ACET - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Adicet Bio|ACET - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sish sur'ati adicetbio.com|ACET - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Adicet Bio
Kompaniyaning har tomonlama tahlili:adicetbio.com ACET
Fundamental aktivlarni tanlash kapital rentabelligini bozor kapitalizatsiyasining sof foydaga nisbati orqali tahlil qilishni talab etadi. Ushbu koeffitsient investitsiyalarning qoplanish muddatini belgilaydi, bu esa FDA tomonidan sertifikatlangan ishlab chiqarishning yuqori xarajatlari va noyob T-hujayralar terapiyasi tufayli Adicet Bio (ACET) uchun juda muhimdir; natijada, kompaniyaning tarixiy o'rtacha P/E ko'rsatkichi biznesning adolatli qiymatini aniqlash imkonini beradi va bozor kutuvlarining cho'qqisida haddan tashqari ko'p to'lov qilishning oldini oladi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati BioCryst (BCRX)|veratx.com - Narx-foyda multiplikatori|P/E multiplikatori DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalizatsiyaning foydaga nisbati|AbCellera Bio - P/E multiplikatori|TRML - P/E multiplikatori|PGEN: P/E multiplikatori|Narx-foyda multiplikatori PHAR|NKTR (Nektar Therapeutics Inc.) - P/E multiplikatori|Upstream Bio, Inc. (UPB) - Biznesning o‘zini qoplash muddati|P/E multiplikatori ZBIO|Narx-foyda koeffitsiyenti Immunome Bio IMNM|P/E multiplikatori GOSS (Gossamer Bio, Inc.)|kalvista.com (KALV) - Kapitalizatsiyaning foydaga nisbati|SEPN: Narx-foyda koeffitsiyenti|Pieris Pharma - Bozor narxining sof foydaga nisbati|SVRA (Savara Corp) - Narx-foyda koeffitsiyenti|Rigel Corp - Kompaniya qiymatining sof foydaga nisbati|ANAB (AnaptysBio, Inc.) - P/E multiplikatori|Narxning foydaga nisbati ATXS|P/E multiplikatori ENGN|Biznesning o‘zini qoplash muddati RAPT Therapeutics Inc.|Narxning foydaga nisbati Aerovate Therapeutics JBIO|Aclaris Therapeutics, Inc (ACRS) - Kapitalizatsiyaning foydaga nisbati|Kyverna Therapeutics - P/E multiplikatori|TLSA - P/E multiplikatori|CABA: P/E multiplikatori|Narx-foyda koeffitsiyenti Ventyx Biosciences Inc.|THTX (Theratechnologies Inc) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Avalo Therapeutics Inc AVTX|Narx-foyda koeffitsiyenti ELDN (Eledon Pharmaceuticals)|Bozor narxining sof foydaga nisbati AGEN|Narxning foydaga nisbati Climb Bio CLYM|ZURA (Zura Bio Ltd) - Kapitalizatsiyaning sof foydaga nisbati|aTyr - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati ADAG (Adagene)|IMA: P/E multiplikatori|Shattuck Labs (STTK) - P/E multiplikatori|Narxning foydaga nisbati Equillium Inc|CNTB: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Immunic, Inc. (IMUX)|Narx-foyda koeffitsiyenti atarabio.com ATRA|P/E multiplikatori IFRX (InflaRx)|P/E multiplikatori x4pharma.com XFOR|CELU: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati INMB (INmune Bio Inc)|BRNS: P/E multiplikatori|KZR - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati SAB Biotherapeutics|Narx-foyda koeffitsiyenti akaritx.com (AKTX)|Narxning foydaga nisbati Enlivex Therapeutics (ENLV)|Narx-foyda koeffitsiyenti q32bio.com QTTB|GeoVax Labs Inc - Narx-foyda koeffitsiyenti|P/E multiplikatori Edesa Biotech Corp EDSA|IBIO - Narxning foydaga nisbati|CARM (Carisma Therapeutics) - Narx-foyda multiplikatori|XTLB: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Bolt Biotherapeutics, Inc. (BOLT)|HCWB (HCW Biologics, Inc.) - P/E multiplikatori|P/E multiplikatori Aptevo|P/E multiplikatori AIM|aditxt.com - Narx-foyda multiplikatori|P/E multiplikatori GRI (GRI Bio)|Biznesning o‘zini qoplash muddati XORTX Therapeutics Inc (XRTX)|ReShape Lifesciences - P/E multiplikatori|Revelation Biosciences Corp (REVB) - Narx-foyda koeffitsiyenti|INDP: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati scinai.com (SCNI)|Narx-foyda koeffitsiyenti CALI|AFMD (Affimed Therapeutics) - Bozor narxining sof foydaga nisbati|Narx-foyda koeffitsiyenti ALLK (Allakos Inc.)|HOOK (hookipapharma.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori IGMS (IGM Biosciences)|iteostherapeutics.com - Narxning foydaga nisbati|Ocean Biomedical - P/E multiplikatori|Biznesning o‘zini qoplash muddati TC BioPharm (Holdings) Plc TCBP|Third Harmonic Bio, Inc (THRD) - Narxning foydaga nisbati
